The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 30, 2022

Filed:

Aug. 23, 2017
Applicant:

Board of Regents, the University of Texas System, Austin, TX (US);

Inventor:

Sanjay Awasthi, Lubbock, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C12N 15/10 (2006.01); C12N 11/18 (2006.01); C12N 15/11 (2006.01); C12N 5/09 (2010.01); C07K 16/40 (2006.01); C12N 15/113 (2010.01); A61P 35/00 (2006.01); C12N 9/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1024 (2013.01); A61P 35/00 (2018.01); C07K 16/40 (2013.01); C12N 5/0693 (2013.01); C12N 11/18 (2013.01); C12N 15/11 (2013.01); C12N 15/113 (2013.01); C07K 2317/34 (2013.01); C07K 2317/73 (2013.01); C12N 9/00 (2013.01); C12N 2310/11 (2013.01); C12N 2310/14 (2013.01); C12N 2310/315 (2013.01);
Abstract

Partial depletion of RLIP76 in p53 deficient living subject has shown many health benefits. In one embodiment, partical Rlip depletion is used to prevent or treat cancer in p53 deficient living subjects. In another embodiment, partial Rlip depletion is used for reversion of DNA-methylation abnormalities caused by the lack of p53 to normal in p53 deficient living subjects. In yet another embodiment, partial Rlip depletion is used in reduction of blood glucose, insulin-resistance, hyperlipidemina, or any combination thereof in p53 deficient living subjects. Methods of using liposome containing anti-sense nucleic acid or double stranded siRNA to partially deplete RLIP76 and thus treat p53 deficient subject are disclosed. The approaches described herein can be especially helpful in preventing cancer in Li-Fraumeni patients.


Find Patent Forward Citations

Loading…